Item 16. Form 10-K Summary.
4K characters. Original on sec.gov · Markdown
Item 16. Form 10-K Summary.
None.
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| ALIGN TECHNOLOGY, INC. | |||||
| By: | /s/ JOSEPH M. HOGAN | ||||
| Joseph M. Hogan | |||||
| President and Chief Executive Officer | |||||
| Date: | February 28, 2025 |
POWER OF ATTORNEY
Each person whose signature appears below constitutes and appoints Joseph M. Hogan or John F. Morici, jointly and severally, his or her attorney-in-fact, each with the full power of substitution, for such person in any and all capacities, to sign any amendments to this Report on Form 10-K and to file the same, with exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, hereby ratifying and confirming all that each of said attorneys-in-fact, or his or her substitute or substitutes, may do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
| Signature | Title | Date | ||||||||||||
| /s/ JOSEPH M. HOGAN | President, Chief Executive Officer and Director (Principal Executive Officer) | February 28, 2025 | ||||||||||||
| Joseph M. Hogan | ||||||||||||||
| /s/ JOHN F. MORICI | Chief Financial Officer and Executive Vice President, Global Finance (Principal Financial Officer and Principal Accounting Officer) | February 28, 2025 | ||||||||||||
| John F. Morici | ||||||||||||||
| /s/ KEVIN T. CONROY | Director | February 28, 2025 | ||||||||||||
| Kevin T. Conroy | ||||||||||||||
| /s/ KEVIN J. DALLAS | Director | February 28, 2025 | ||||||||||||
| Kevin J. Dallas | ||||||||||||||
| /s/ JOSEPH LACOB | Director | February 28, 2025 | ||||||||||||
| Joseph Lacob | ||||||||||||||
| /s/ C. RAYMOND LARKIN, JR. | Chairman of the Board | February 28, 2025 | ||||||||||||
| C. Raymond Larkin, Jr. | ||||||||||||||
| /s/ GEORGE J. MORROW | Director | February 28, 2025 | ||||||||||||
| George J. Morrow | ||||||||||||||
| /s/ ANNE M. MYONG | Director | February 28, 2025 | ||||||||||||
| Anne M. Myong | ||||||||||||||
| /s/ MOJDEH POUL | Director | February 28, 2025 | ||||||||||||
| Mojdeh Poul | ||||||||||||||
| /s/ ANDREA L. SAIA | Director | February 28, 2025 | ||||||||||||
| Andrea L. Saia | ||||||||||||||
| /s/ SUSAN E. SIEGEL | Director | February 28, 2025 | ||||||||||||
| Susan E. Siegel |
Previous: Item 15. Exhibit and Financial Statement Schedules.